Kevin R. McIntosh

Health Technology

Consumer Services

Profile

Dr. Kevin R.
McIntosh is Senior Research Director at Cognate BioServices, Inc. Dr. McIntosh was previously employed as a Principal by Osiris Therapeutics, Inc. He received his undergraduate degree from the University of Illinois, a graduate degree from the University of Illinois, and a doctorate degree from the University of Illinois.

Former positions of Kevin R. McIntosh

Companies	Position	End
OSIRIS THERAPEUTICS, INC.	Corporate Officer/Principal	-
Cognate BioServices, Inc. Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN.	Chief Tech/Sci/R&D Officer	-

See the detail of Kevin R. McIntosh's experience

Training of Kevin R. McIntosh

University of Illinois

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kevin R. McIntosh's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Cognate BioServices, Inc. Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN.	Health Technology
Osiris Therapeutics, Inc. Osiris Therapeutics, Inc. BiotechnologyHealth Technology Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.	Health Technology